The use of the synthetic peptides gamma-type endorphins in mentally ill patients.
D000328:Adult; D001921:Brain / Q000378:metabolism; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000378:metabolism; D004311:Double-Blind Method; D004723:Endorphins / Q000502:physiology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000627:therapeutic use; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D001615:beta-Endorphin; D018823:gamma-Endorphin
D004723:Endorphins; D010446:Peptide Fragments; D001615:beta-Endorphin; D018823:gamma-Endorphin; C018903:gamma-endorphin, des-Tyr(1)-; C033558:des-enkephalin-gamma-endorphin; D004298:Dopamine